BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
42.095 EUR
+0.42 (+1.02%)
BAYN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 53 industry peers in the Pharmaceuticals industry. BAYN may be in some trouble as it scores bad on both profitability and health. BAYN is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- BAYN had positive earnings in the past year.
- BAYN had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
- Each year in the past 5 years BAYN had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.19%, BAYN is doing worse than 67.92% of the companies in the same industry.
- The Return On Equity of BAYN (-0.67%) is worse than 67.92% of its industry peers.
- BAYN has a worse Return On Invested Capital (1.80%) than 66.04% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for BAYN is significantly below the industry average of 14.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.8% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
1.3 Margins
- BAYN has a Operating Margin of 4.20%. This is in the lower half of the industry: BAYN underperforms 66.04% of its industry peers.
- BAYN's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 56.35%, BAYN is doing worse than 69.81% of the companies in the same industry.
- BAYN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
- BAYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for BAYN remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, BAYN has about the same amount of shares outstanding.
- The debt/assets ratio for BAYN has been reduced compared to a year ago.
2.2 Solvency
- BAYN has an Altman-Z score of 0.99. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
- BAYN's Altman-Z score of 0.99 is on the low side compared to the rest of the industry. BAYN is outperformed by 67.92% of its industry peers.
- BAYN has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as BAYN would need 10.07 years to pay back of all of its debts.
- The Debt to FCF ratio of BAYN (10.07) is worse than 60.38% of its industry peers.
- A Debt/Equity ratio of 1.11 is on the high side and indicates that BAYN has dependencies on debt financing.
- BAYN has a Debt to Equity ratio of 1.11. This is in the lower half of the industry: BAYN underperforms 66.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 0.99 |
ROIC/WACC0.27
WACC6.66%
2.3 Liquidity
- BAYN has a Current Ratio of 1.14. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
- BAYN has a worse Current ratio (1.14) than 62.26% of its industry peers.
- BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
- BAYN's Quick ratio of 0.71 is on the low side compared to the rest of the industry. BAYN is outperformed by 69.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
- The earnings per share for BAYN have decreased by -8.72% in the last year.
- BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
- Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -1.87% in the last year.
- Measured over the past years, BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
- Based on estimates for the next years, BAYN will show a small growth in Earnings Per Share. The EPS will grow by 3.51% on average per year.
- BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.22% yearly.
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.51%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.88, the valuation of BAYN can be described as very cheap.
- Based on the Price/Earnings ratio, BAYN is valued cheaply inside the industry as 96.23% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of BAYN to the average of the S&P500 Index (27.33), we can say BAYN is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 8.65, the valuation of BAYN can be described as reasonable.
- Based on the Price/Forward Earnings ratio, BAYN is valued cheaply inside the industry as 90.57% of the companies are valued more expensively.
- BAYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.88 | ||
| Fwd PE | 8.65 |
4.2 Price Multiples
- 62.26% of the companies in the same industry are more expensive than BAYN, based on the Enterprise Value to EBITDA ratio.
- BAYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BAYN is cheaper than 88.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.51 | ||
| EV/EBITDA | 11.71 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
5. Dividend
5.1 Amount
- BAYN has a yearly dividend return of 0.28%, which is pretty low.
- BAYN's Dividend Yield is slightly below the industry average, which is at 1.72.
- With a Dividend Yield of 0.28, BAYN pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.28% |
5.2 History
- The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-65.15%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
FRA:BAYN (1/15/2026, 5:36:15 PM)
42.095
+0.42 (+1.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners49.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap41.35B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts74.29
Price Target34.35 (-18.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.28% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)5.41%
PT rev (3m)18.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.41%
EPS NY rev (1m)0.49%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.88 | ||
| Fwd PE | 8.65 | ||
| P/S | 0.9 | ||
| P/FCF | 10.51 | ||
| P/OCF | 6.15 | ||
| P/B | 1.4 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.71 |
EPS(TTM)5.34
EY12.69%
EPS(NY)4.87
Fwd EY11.57%
FCF(TTM)4.01
FCFY9.52%
OCF(TTM)6.84
OCFY16.26%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.8% | ||
| ROICexc | 2% | ||
| ROICexgc | 6.8% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.99 |
F-Score5
WACC6.66%
ROIC/WACC0.27
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.51%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.28%
EBIT Next 3Y21.41%
EBIT Next 5Y12.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status of BAYER AG-REG (BAYN.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
How financially healthy is BAYER AG-REG?
The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.
How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.